2024-01-012024-12-312024-12-31false01972114Clydebridge Chemicals Limited2025-12-22falseiso4217:GBPxbrli:pure019721142023-12-31019721142024-12-31019721142024-01-012024-12-31019721142022-12-31019721142023-12-31019721142023-01-012023-12-3101972114bus:SmallEntities2024-01-012024-12-3101972114bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3101972114bus:FullAccounts2024-01-012024-12-3101972114bus:PrivateLimitedCompanyLtd2024-01-012024-12-3101972114core:WithinOneYear2024-12-3101972114core:AfterOneYear2024-12-3101972114core:WithinOneYear2023-12-3101972114core:AfterOneYear2023-12-3101972114core:ShareCapital2024-12-3101972114core:SharePremium2024-12-3101972114core:RevaluationReserve2024-12-3101972114core:OtherReservesSubtotal2024-12-3101972114core:RetainedEarningsAccumulatedLosses2024-12-3101972114core:ShareCapital2023-12-3101972114core:SharePremium2023-12-3101972114core:RevaluationReserve2023-12-3101972114core:OtherReservesSubtotal2023-12-3101972114core:RetainedEarningsAccumulatedLosses2023-12-3101972114core:LandBuildings2024-12-3101972114core:PlantMachinery2024-12-3101972114core:Vehicles2024-12-3101972114core:FurnitureFittings2024-12-3101972114core:OfficeEquipment2024-12-3101972114core:NetGoodwill2024-12-3101972114core:IntangibleAssetsOtherThanGoodwill2024-12-3101972114core:ListedExchangeTraded2024-12-3101972114core:UnlistedNon-exchangeTraded2024-12-3101972114core:LandBuildings2023-12-3101972114core:PlantMachinery2023-12-3101972114core:Vehicles2023-12-3101972114core:FurnitureFittings2023-12-3101972114core:OfficeEquipment2023-12-3101972114core:NetGoodwill2023-12-3101972114core:IntangibleAssetsOtherThanGoodwill2023-12-3101972114core:ListedExchangeTraded2023-12-3101972114core:UnlistedNon-exchangeTraded2023-12-3101972114core:LandBuildings2024-01-012024-12-3101972114core:PlantMachinery2024-01-012024-12-3101972114core:Vehicles2024-01-012024-12-3101972114core:FurnitureFittings2024-01-012024-12-3101972114core:OfficeEquipment2024-01-012024-12-3101972114core:NetGoodwill2024-01-012024-12-3101972114core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3101972114core:ListedExchangeTraded2024-01-012024-12-3101972114core:UnlistedNon-exchangeTraded2024-01-012024-12-3101972114core:MoreThanFiveYears2024-01-012024-12-3101972114core:Non-currentFinancialInstruments2024-12-3101972114core:Non-currentFinancialInstruments2023-12-3101972114dpl:CostSales2024-01-012024-12-3101972114dpl:DistributionCosts2024-01-012024-12-3101972114core:LandBuildings2024-01-012024-12-3101972114core:PlantMachinery2024-01-012024-12-3101972114core:Vehicles2024-01-012024-12-3101972114core:FurnitureFittings2024-01-012024-12-3101972114core:OfficeEquipment2024-01-012024-12-3101972114dpl:AdministrativeExpenses2024-01-012024-12-3101972114core:NetGoodwill2024-01-012024-12-3101972114core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3101972114dpl:GroupUndertakings2024-01-012024-12-3101972114dpl:ParticipatingInterests2024-01-012024-12-3101972114dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3101972114core:ListedExchangeTraded2024-01-012024-12-3101972114dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3101972114core:UnlistedNon-exchangeTraded2024-01-012024-12-3101972114dpl:CostSales2023-01-012023-12-3101972114dpl:DistributionCosts2023-01-012023-12-3101972114core:LandBuildings2023-01-012023-12-3101972114core:PlantMachinery2023-01-012023-12-3101972114core:Vehicles2023-01-012023-12-3101972114core:FurnitureFittings2023-01-012023-12-3101972114core:OfficeEquipment2023-01-012023-12-3101972114dpl:AdministrativeExpenses2023-01-012023-12-3101972114core:NetGoodwill2023-01-012023-12-3101972114core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3101972114dpl:GroupUndertakings2023-01-012023-12-3101972114dpl:ParticipatingInterests2023-01-012023-12-3101972114dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3101972114core:ListedExchangeTraded2023-01-012023-12-3101972114dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3101972114core:UnlistedNon-exchangeTraded2023-01-012023-12-3101972114core:NetGoodwill2024-12-3101972114core:IntangibleAssetsOtherThanGoodwill2024-12-3101972114core:LandBuildings2024-12-3101972114core:PlantMachinery2024-12-3101972114core:Vehicles2024-12-3101972114core:FurnitureFittings2024-12-3101972114core:OfficeEquipment2024-12-3101972114core:AfterOneYear2024-12-3101972114core:WithinOneYear2024-12-3101972114core:ListedExchangeTraded2024-12-3101972114core:UnlistedNon-exchangeTraded2024-12-3101972114core:ShareCapital2024-12-3101972114core:SharePremium2024-12-3101972114core:RevaluationReserve2024-12-3101972114core:OtherReservesSubtotal2024-12-3101972114core:RetainedEarningsAccumulatedLosses2024-12-3101972114core:NetGoodwill2023-12-3101972114core:IntangibleAssetsOtherThanGoodwill2023-12-3101972114core:LandBuildings2023-12-3101972114core:PlantMachinery2023-12-3101972114core:Vehicles2023-12-3101972114core:FurnitureFittings2023-12-3101972114core:OfficeEquipment2023-12-3101972114core:AfterOneYear2023-12-3101972114core:WithinOneYear2023-12-3101972114core:ListedExchangeTraded2023-12-3101972114core:UnlistedNon-exchangeTraded2023-12-3101972114core:ShareCapital2023-12-3101972114core:SharePremium2023-12-3101972114core:RevaluationReserve2023-12-3101972114core:OtherReservesSubtotal2023-12-3101972114core:RetainedEarningsAccumulatedLosses2023-12-3101972114core:NetGoodwill2022-12-3101972114core:IntangibleAssetsOtherThanGoodwill2022-12-3101972114core:LandBuildings2022-12-3101972114core:PlantMachinery2022-12-3101972114core:Vehicles2022-12-3101972114core:FurnitureFittings2022-12-3101972114core:OfficeEquipment2022-12-3101972114core:AfterOneYear2022-12-3101972114core:WithinOneYear2022-12-3101972114core:ListedExchangeTraded2022-12-3101972114core:UnlistedNon-exchangeTraded2022-12-3101972114core:ShareCapital2022-12-3101972114core:SharePremium2022-12-3101972114core:RevaluationReserve2022-12-3101972114core:OtherReservesSubtotal2022-12-3101972114core:RetainedEarningsAccumulatedLosses2022-12-3101972114core:AfterOneYear2024-01-012024-12-3101972114core:WithinOneYear2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3101972114core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3101972114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3101972114core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3101972114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3101972114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3101972114bus:Director12024-01-012024-12-3101972114bus:Director22024-01-012024-12-3101972114core:FurnitureFittingsToolsEquipment2023-12-3101972114core:FurnitureFittingsToolsEquipment2024-01-012024-12-3101972114core:FurnitureFittingsToolsEquipment2024-12-31

Clydebridge Chemicals Limited

Registered Number
01972114
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

Clydebridge Chemicals Limited
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

Jacob Froggett
Martin Pisacane

Registered Address

7 Darwin Close
Reading
RG2 0TB

Registered Number

01972114 (England and Wales)
Clydebridge Chemicals Limited
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3415,754152,292
415,754152,292
Current assets
Stocks4528,267622,454
Debtors5702,3301,315,617
Cash at bank and on hand18,66236
1,249,2591,938,107
Creditors amounts falling due within one year6(496,618)(693,005)
Net current assets (liabilities)752,6411,245,102
Total assets less current liabilities1,168,3951,397,394
Creditors amounts falling due after one year7(34,576)(34,491)
Provisions for liabilities8(103,939)(384,040)
Net assets1,029,880978,863
Capital and reserves
Called up share capital10,00010,000
Profit and loss account1,019,880968,863
Shareholders' funds1,029,880978,863
The financial statements were approved and authorised for issue by the Board of Directors on 22 December 2025, and are signed on its behalf by:
Jacob Froggett
Director
Martin Pisacane
Director

Registered Company No. 01972114
Clydebridge Chemicals Limited
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Borrowing costs
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings4.2
Plant and machinery4.2
Fixtures and fittings4.2
Office Equipment4.2
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Trade and other debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20242023
Average number of employees during the year1413
3.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 January 24770830,618198,5074,7401,034,635
Additions28,280331,61122,911347383,149
At 31 December 2429,0501,162,229221,4185,0871,417,784
Depreciation and impairment
At 01 January 2435762,611118,992705882,343
Charge for year2,00581,91834,5571,207119,687
At 31 December 242,040844,529153,5491,9121,002,030
Net book value
At 31 December 2427,010317,70067,8693,175415,754
At 31 December 2373568,00779,5154,035152,292
4.Stocks

2024

2023

££
Other stocks528,267622,454
Total528,267622,454
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables692,328944,402
Other debtors3,013360,586
Prepayments and accrued income6,98910,629
Total702,3301,315,617
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables426,597389,293
Bank borrowings and overdrafts20,881107,825
Taxation and social security26,272113,479
Other creditors18,07377,908
Accrued liabilities and deferred income4,7954,500
Total496,618693,005
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts34,57634,491
Total34,57634,491
8.Provisions for liabilities
Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

2024

2023

££
Net deferred tax liability (asset)103,93928,935
Other provisions-355,105
Total103,939384,040
9.Other commitments
Included in the balance sheet are contingencies of £Nil (2023 - £355,105). The provision relates to certain land and remediation costs. Included in the balance sheet are pensions of £2,018 (2023 - £2,179). The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £19,264 (2023: £18,050). At the reporting date an amount of £2,018 (2023: £2,179) is outstanding and is included within creditors.
10.Related party transactions
The Company is a wholly owned subsidiary and has taken advantage of the exemption under Section 1A of FRS 102 not to disclose transactions with either of its parent companies.
11.Parent-subsidiary relationships
The company's immediate parent is Clydebridge Group Limited, incorporated in England & Wales. The ultimate parent is Kennet Island, incorporated in England & Wales.